1 Introduction 8

• 1.1 Industry Definition and Research Scope 8
  • 1.1.1 Industry Definition 8
  • 1.1.2 Research Scope 9
• 1.2 Research Methodology 12
  • 1.2.1 Overview of Market Research Methodology 12
  • 1.2.2 Market Assumption 13
  • 1.2.3 Secondary Data 13
  • 1.2.4 Primary Data 13
  • 1.2.5 Data Filtration and Model Design 15
  • 1.2.6 Market Size/Share Estimation 16
  • 1.2.7 Research Limitations 17
• 1.3 Executive Summary 18

2 Market Overview and Dynamics 21

• 2.1 Market Size and Forecast 21
  • 2.1.1 Impact of COVID-19 on the Market 22
• 2.2 Major Growth Drivers 24
• 2.3 Market Restraints and Challenges 27
• 2.4 Emerging Opportunities and Market Trends 30
• 2.5 Porter’s Fiver Forces Analysis 34

3 Segmentation of Global Market by Product Type 38

• 3.1 Market Overview by Product Type 38
• 3.2 Electronic Health Records (EHRs) 40
• 3.3 Population Health Management (PHM) 42
• 3.4 Clinical Decision Support System (CDSS) 44
• 3.5 Drug Discovery and Development Informatics (DDDI) 46
• 3.6 Data Analytics 48
• 3.7 Image Analytics 49
• 3.8 Other Product Types 50

4 Segmentation of Global Market by Cancer Type 51

• 4.1 Market Overview by Cancer Type 51
• 4.2 Colorectal Cancer 53
• 4.3 Breast Cancer 54
• 4.4 Prostate Cancer 55
• 4.5 Cervical Cancer 56

5 Segmentation of Global Market by Application 57

• 5.1 Market Overview by Application 57
• 5.2 Medical Application 59
• 5.3 Surgical Application 60
• 5.4 Radiation Application 61

6 Segmentation of Global Market by End User 63

• 6.1 Market Overview by End User 63
• 6.2 Pharmaceutical Companies 65
• 6.3 Life Science Companies 66
• 6.4 Contract Research Organizations (CROs) 67
• 6.5 Academic Institutes and Research Centers 68
• 6.6 Other End Users 69

7 Segmentation of Global Market by Region 70

• 7.1 Geographic Market Overview 2019-2030 70
• 7.2 North America Market 2019-2030 by Country 74
  • 7.2.1 Overview of North America Market 74
  • 7.2.2 U.S. 78
  • 7.2.3 Canada 82
  • 7.2.4 Mexico 84
• 7.3 European Market 2019-2030 by Country 86
  • 7.3.1 Overview of European Market 86
  • 7.3.2 Germany 90
  • 7.3.3 UK 92
  • 7.3.4 France 94
  • 7.3.5 Spain 96
  • 7.3.6 Italy 98
  • 7.3.7 Russia 100
  • 7.3.8 Rest of European Market 102
• 7.4 Asia-Pacific Market 2019-2030 by Country 104
  • 7.4.1 Overview of Asia-Pacific Market 104
  • 7.4.2 Japan 108
  • 7.4.3 China 111
  • 7.4.4 Australia 113
  • 7.4.5 India 115
  • 7.4.6 South Korea 117
  • 7.4.7 Rest of APAC Region 119
• 7.5 South America Market 2019-2030 by Country 121
  • 7.5.1 Argentina 124
  • 7.5.2 Brazil 126
  • 7.5.3 Chile 128
  • 7.5.4 Rest of South America Market 130
• 7.6 MEA Market 2019-2030 by Country 131
  • 7.6.1 UAE 134
  • 7.6.2 Saudi Arabia 136
  • 7.6.3 South Africa 138
  • 7.6.4 Other National Markets 140

8 Competitive Landscape 141

• 8.1 Overview of Key Vendors 141
• 8.2 New Product Launch, Partnership, Investment, and M&A 145
• 8.3 Company Profiles 146

Cerner Corporation 146

Change Healthcare 148

Elekta AB 149

F.Hoffmann-La Roche Ltd. 150

Hologic Inc. 151

IBM Corporation 152

Inspirata Inc. 153

Koninklijke Philips N.V. 154

Laboratory Corporation of America Holdings 155

McKesson Corporation 156

MIM Software, Inc. 157

Oncology Analytics, Inc 158

PerkinElmer, Inc. 159

RELX Group 160

Sirenas, LLC 161

UnitedHealth Group, Inc 162

Varian Medical Systems, Inc 163

9 Investing in Global Market: Risk Assessment and Management 164

• 9.1 Risk Evaluation of Global Market 164
• 9.2 Critical Success Factors (CSFs) 167

Related Reports and Products 170

Global oncology informatics market will reach $8,602.3 million by 2030, growing by 6.1% annually over 2020-2030 driven by the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates.
Highlighted with 87 tables and 79 figures, this 170-page report “Global Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Electronic Health Records (EHRs)
• Population Health Management (PHM)
• Clinical Decision Support System (CDSS)
• Drug Discovery and Development Informatics (DDDI)
• Data Analytics
• Image Analytics
• Other Product Types

Based on Cancer Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Other Cancers

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Medical Application
• Surgical Application
• Radiation Application

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical Companies
• Life Science Companies
• Contract Research Organizations (CROs)
• Academic Institutes and Research Centers
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global oncology informatics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)